R-CMC544
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-CMC544, covering 2016-05-23 to 2016-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse [Phase 1, Phase 2]